15 The infants in these studies had evidence of suboptimal vitamin B 12 status, but none was severely deficient
The pharmacokinetic profile does not change with repeated administration
Due to their cost, however, coverage of GLP-1s for obesity treatment in Medicaid, ACA Marketplace plans, and most large employer firms remains limited, and GLP-1 coverage in Medicare for treatment of obesity is prohibited under current law
Patients with a history of thrombocytopenia or any other hematologic disorder should also avoid using this formulation
However, it is best to follow guidelines from a healthcare professional
Understanding how each therapy works can help explain why their results, benefits, and side effect profiles differ